Two notions about schizophrenia have persisted: (1) it is characterized by
onset in adolescence or early adulthood. and (2) it has a progressively det
eriorating course. Recent studies focusing on early-adulthood- and middle-a
ge-onset schizophrenia challenge these views. Patients with early-onset sch
izophrenia and middle-age-onset schizophrenia (MAOS) are similar in terms o
f family history of schizophrenia, presence of minor physical anomalies, ea
rly childhood maladjustment, severity of positive symptoms, presence of gro
ss structural abnormalities on cerebral magnetic resonance imaging, overall
pattern of neuropsychologic deficits, and qualitative response to neurolep
tic medications. Differences include a higher proportion of women among MAO
S patients, and the tendency for MAOS patients to have less severe negative
symptoms, better neuropsychologic performance (particularly in learning an
d abstraction/cognitive flexibility), and possibly larger thalamic volume a
nd to respond to lower doses of neuroleptic medications. While onset of sch
izophrenia-like symptoms in very late life may reflect an acquired conditio
n that is not "true schizophrenia," and that may be labeled "very-late-onse
t schizophrenia-like psychosis," findings suggest that true schizophrenia c
an arise after early adulthood. Middle-age-onset schizophrenia is predomina
ntly neurodevelopmental, but it is also a distinct neurobiological subtype
of schizophrenia. Our studies also demonstrate that neuropsychologic functi
oning remains stable in chronic schizophrenia outpatients, even when observ
ed over several years and in the presence of significant fluctuations in th
e severity of clinical symptoms.